Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "NSE"

2554 News Found

Illuminova ’26 showcases AI-driven future of medical education at SRM
Healthcare | April 29, 2026

Illuminova ’26 showcases AI-driven future of medical education at SRM

SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence


AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata
Drug Approval | April 29, 2026

AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata

After Phase 3 results show major hair regrowth gains


FDA okays AstraZeneca’s triple therapy Breztri for asthma
Medical Device | April 29, 2026

FDA okays AstraZeneca’s triple therapy Breztri for asthma

The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device


Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation
Healthcare | April 29, 2026

Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation

Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform


The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
interviews | April 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints


Apollo launches its 76th hospital, boosts tech-led healthcare in India
Hospitals | April 28, 2026

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof


Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers
Biopharma | April 28, 2026

Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers

Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026


Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report
Biopharma | April 28, 2026

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation


EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control
Medical Device | April 28, 2026

EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control

The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs


Stryker launches Trident II Hip System in India
Medical Device | April 28, 2026

Stryker launches Trident II Hip System in India

New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty